BBNX · NASDAQ
Beta Bionics (BBNX) Stock Price & Fundamentals
Beta Bionics (BBNX) closed at $971.69 on Oct 9, 2026, up 0.96% from the previous close of $962.47.
Share price, past year
1Y +17.23%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $971.69 |
| Sep 30, 2026 | $954.66 |
| Aug 31, 2026 | $963.93 |
| Jul 31, 2026 | $919.33 |
| Jun 30, 2026 | $942.14 |
| May 29, 2026 | $944.26 |
| Apr 30, 2026 | $916.15 |
| Mar 31, 2026 | $889.60 |
| Feb 27, 2026 | $884.23 |
| Jan 30, 2026 | $898.15 |
| Dec 31, 2025 | $962.73 |
| Nov 28, 2025 | $879.97 |
| Oct 31, 2025 | $876.68 |
Key statistics
- Market cap
- $43.71B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.51
- Revenue (TTM)
- $119.01M
- Net income (TTM)
- −$72.97M
- Shares outstanding
- 45M
- Dividend yield
- —
- 52-week range
- $828.89 – $973.01
Beta Bionics's market cap is $43.71B, based on a share price of $971.69 and 45M shares outstanding as of Jun 30, 2026.
Financials
Beta Bionics reported revenue of $100.25M for fiscal 2025, up 53.94% from fiscal 2024.
Beta Bionics reported a net loss of $73.20M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $100.25M | +53.9% | −$73.20M | −73.0% | −$1.81 | −$56.22M |
| FY2024ended Dec 31, 2024 | $65.12M | +442.9% | −$54.76M | −84.1% | −$8.60 | −$51.67M |
| FY2023ended Dec 31, 2023 | $12.00M | — | −$44.10M | −367.6% | −$8.31 | −$32.85M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $32.01M | −$23.40M | −$0.53 |
| Q1 FY2026ended Mar 31, 2026 | $27.63M | −$21.90M | −$0.49 |
| Q4 FY2025ended Dec 31, 2025 | $32.12M | −$13.47M | −$0.16 |
| Q3 FY2025ended Sep 30, 2025 | $27.25M | −$14.21M | −$0.33 |
| Q2 FY2025ended Jun 30, 2025 | $23.24M | −$16.87M | −$0.39 |
| Q1 FY2025ended Mar 31, 2025 | $17.64M | −$28.66M | −$0.93 |
| Q4 FY2024ended Dec 31, 2024 | $20.44M | −$18.11M | −$2.70 |
| Q3 FY2024ended Sep 30, 2024 | $16.71M | −$9.74M | −$1.46 |
Company profile
- Name
- Beta Bionics, Inc.
- Ticker
- BBNX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 11 Hughes, Irvine, CA 92618
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001674632
Recent SEC filings
- Sep 17, 2026
- Sep 15, 2026
- Jul 29, 2026
- Jul 29, 2026
- May 22, 2026
- May 21, 2026
- Apr 21, 2026
- Apr 21, 2026
Frequently asked questions
What is Beta Bionics's stock price?
Beta Bionics (BBNX) closed at $971.69 on Oct 9, 2026, up 0.96% from the previous close of $962.47.
What is Beta Bionics's market cap?
Beta Bionics's market cap is $43.71B, based on a share price of $971.69 and 45M shares outstanding as of Jun 30, 2026.
How much revenue does Beta Bionics make?
Beta Bionics reported revenue of $100.25M for fiscal 2025, up 53.94% from fiscal 2024.
Does Beta Bionics pay a dividend?
Beta Bionics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Beta Bionics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures